论文信息 - Imatinib or transplant for chronic myeloid leukaemia? - 字舞流文

Imatinib or transplant for chronic myeloid leukaemia?

C. Craddock | B. Augustson | S. Basu

[1] E. Sausville. Imatinib for chronic myelogenous leukaemia: a 9 or 24 carat gold standard? , 2003, The Lancet.

[2] A. Nagler,et al. Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phase. , 2003, Blood.

[3] Jonas Mattsson,et al. Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation. , 2003, Blood.

[4] R. Larson,et al. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. , 2002, Blood.

[5] C. Kollman,et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. , 2002, Blood.

[6] B. Druker,et al. Chronic myeloid leukemia: current treatment options. , 2001, Blood.

[7] J Hermans,et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation , 1998, The Lancet.